PEN – Penumbra, Inc.
Penumbra, Inc.PEN
$321.68Name : Penumbra, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $12,678,818,816.00
EPSttm : 3.97
Penumbra, Inc.
$321.68
0.07%$0.22
PEN — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
5.91
Margin Of Safety %
-16
Put/Call OI Ratio
3.11
EPS Next Q Diff
EPS Last/This Y
1.06
EPS This/Next Y
1.26
Price
321.39
Target Price
364.25
Analyst Recom
2.82
Performance Q
-1.59
Upside
-56.8%
Beta
0.69
Ticker: PEN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | PEN | 320.96 | 2.23 | 138.00 | 12963 |
| 2026-10-13 | PEN | 319.95 | 2.25 | 196.00 | 13055 |
| 2026-10-14 | PEN | 320.14 | 2.29 | 18.67 | 13183 |
| 2026-10-15 | PEN | 321.27 | 2.35 | 42.33 | 13484 |
| 2026-10-16 | PEN | 320.9 | 2.40 | 999.99 | 13706 |
| 2026-10-19 | PEN | 322.42 | 2.60 | 11.85 | 11624 |
| 2026-10-20 | PEN | 324.27 | 2.64 | 21.25 | 11774 |
| 2026-10-21 | PEN | 323.67 | 2.68 | 999.99 | 11909 |
| 2026-10-22 | PEN | 325.11 | 2.78 | 4.56 | 12224 |
| 2026-10-23 | PEN | 324.73 | 2.79 | 45.33 | 12254 |
| 2026-10-26 | PEN | 325.17 | 2.79 | 33.11 | 12276 |
| 2026-10-27 | PEN | 324.14 | 2.82 | 999.99 | 12354 |
| 2026-10-28 | PEN | 318.4 | 2.80 | 999.99 | 12305 |
| 2026-10-29 | PEN | 321.84 | 3.07 | 20.80 | 13172 |
| 2026-10-30 | PEN | 319.24 | 3.10 | 999.99 | 13339 |
| 2026-11-02 | PEN | 321.34 | 3.11 | 999.99 | 13365 |
| 2026-11-03 | PEN | 319.93 | 3.12 | 34.00 | 13400 |
| 2026-11-04 | PEN | 322.44 | 3.12 | 79.00 | 13410 |
| 2026-11-05 | PEN | 321.21 | 3.12 | 87.00 | 13410 |
| 2026-11-06 | PEN | 319.31 | 3.12 | 87.00 | 13410 |
| 2026-11-09 | PEN | 321.88 | 3.12 | 87.00 | 13410 |
| 2026-11-10 | PEN | 321.38 | 3.11 | 13.26 | 13366 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | PEN | 320.97 | 21.9 | 68.2 | 4.79 |
| 2026-10-13 | PEN | 320.09 | 21.9 | 66.1 | 4.79 |
| 2026-10-14 | PEN | 320.15 | 21.9 | 67.0 | 4.81 |
| 2026-10-15 | PEN | 321.27 | 21.9 | 68.0 | 4.81 |
| 2026-10-16 | PEN | 320.86 | 21.9 | 66.6 | 4.81 |
| 2026-10-19 | PEN | 322.62 | 21.9 | 68.4 | 4.81 |
| 2026-10-20 | PEN | 322.62 | 21.9 | 68.4 | 4.81 |
| 2026-10-21 | PEN | 324.43 | 21.9 | 70.0 | 4.81 |
| 2026-10-22 | PEN | 325.10 | 21.9 | 68.2 | 4.81 |
| 2026-10-23 | PEN | 324.78 | 21.9 | 66.6 | 4.81 |
| 2026-10-26 | PEN | 325.08 | 21.9 | 67.5 | 4.81 |
| 2026-10-27 | PEN | 324.08 | 21.9 | 65.9 | 4.78 |
| 2026-10-28 | PEN | 318.39 | 21.9 | 60.9 | 4.78 |
| 2026-10-29 | PEN | 321.89 | 21.9 | 70.0 | 4.78 |
| 2026-10-30 | PEN | 318.95 | 21.9 | 64.2 | 4.78 |
| 2026-11-02 | PEN | 321.35 | 25.2 | 65.0 | 4.78 |
| 2026-11-04 | PEN | 322.49 | 24.7 | 65.1 | 4.90 |
| 2026-11-05 | PEN | 321.24 | 24.7 | 61.9 | 4.90 |
| 2026-11-06 | PEN | 319.39 | 25.5 | 61.4 | 4.90 |
| 2026-11-09 | PEN | 321.87 | 25.5 | 65.3 | 4.90 |
| 2026-11-10 | PEN | 321.39 | 25.5 | 62.5 | 4.90 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | PEN | 0.00 | 1.87 | 5.87 |
| 2026-10-13 | PEN | 0.00 | 1.87 | 5.87 |
| 2026-10-14 | PEN | 0.00 | 1.87 | 5.87 |
| 2026-10-15 | PEN | 0.00 | 1.87 | 5.87 |
| 2026-10-16 | PEN | 0.00 | 1.87 | 5.87 |
| 2026-10-19 | PEN | 0.00 | 1.81 | 5.87 |
| 2026-10-20 | PEN | 0.00 | 1.81 | 5.87 |
| 2026-10-21 | PEN | 0.00 | 1.81 | 5.87 |
| 2026-10-22 | PEN | 0.00 | 1.81 | 5.87 |
| 2026-10-23 | PEN | 0.00 | 1.81 | 5.87 |
| 2026-10-26 | PEN | 0.00 | 1.81 | 5.87 |
| 2026-10-27 | PEN | 0.00 | 1.81 | 5.91 |
| 2026-10-28 | PEN | 0.00 | 1.81 | 5.91 |
| 2026-10-29 | PEN | 0.00 | 1.81 | 5.91 |
| 2026-10-30 | PEN | 0.00 | 1.81 | 5.91 |
| 2026-11-02 | PEN | 0.00 | 2.86 | 5.91 |
| 2026-11-03 | PEN | 0.00 | 2.86 | 5.91 |
| 2026-11-05 | PEN | 0.00 | 2.86 | 5.91 |
| 2026-11-06 | PEN | 0.00 | 2.86 | 5.91 |
| 2026-11-09 | PEN | 0.00 | 1.92 | 5.91 |
| 2026-11-10 | PEN | 0.00 | 1.92 | 5.91 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
1.48
Avg. EPS Est. Next Quarter
1.4
Insider Transactions
Institutional Transactions
1.92
Beta
0.69
Average Sales Estimate Current Quarter
430
Average Sales Estimate Next Quarter
423
Fair Value
270.19
Quality Score
94
Growth Score
98
Sentiment Score
70
Actual DrawDown %
11.3
Max Drawdown 5-Year %
-59.6
Target Price
364.25
P/E
80.9
Forward P/E
54.08
PEG
2.49
P/S
8.12
P/B
8
P/Free Cash Flow
63.24
EPS
3.97
Average EPS Est. Cur. Y
4.9
EPS Next Y. (Est.)
6.16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.06
Relative Volume
0.69
Return on Equity vs Sector %
-16.4
Return on Equity vs Industry %
-1
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
62.5
◆
PEN
Healthcare
$321.38
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
50.7
Range 1M
55.8%
Sup Dist
0.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
21.3%
EPS NY
27.6%
52W%
55.1%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-18.6% upside
Upside
-18.6%
Quality
94
MoS
-16%
PEN — P/E HistoricalMedical Devices
Penumbra, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 4700
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
PEN
Latest News
—
Caricamento notizie per PEN…
stock quote shares PEN – Penumbra, Inc. Stock Price stock today
news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PEN – Penumbra, Inc. yahoo finance google finance
stock history PEN – Penumbra, Inc. invest stock market
stock prices PEN premarket after hours
ticker PEN fair value insiders trading